Skip to main content
Log in

Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The aim of the study was to assess the duration of the haemodynamic effects of a new sustained-release oral formulation of isosorbide dinitrate (ISDN). Twenty patients (17 men and 3 women; mean age 60 years) with acute myocardial infarction (10 anterior, 10 inferior) complicated by moderate left ventricular failure took part in a randomized controlled trial. Ten patients were randomly assigned to the placebo group and 10 to the ISDN group, who received 40 mg sustained release isosorbide dinitrate. Haemodynamic variables were measured before treatment, after 0.5 and 1 h and then every 2 hours up to the 8th hour after treatment. There was no significant change in any haemodynamic parameter in the placebo group, during the study period. In the ISDN group there was a significant fall in pulmonary artery diastolic pressure at 4 and 8 h, from 19.0±1.0 mmHg to 16.5±1.2 mmHg and 15.5±0.8 mmHg, respectively. The mean pulmonary capillary wedge pressure fell progressively from 17.9±1.0 to 12.5±1.2 mmHg at 2 h (p<0.001 in comparison with the placebo group. The fall remained significant up to 8 h. There was no statistically significant change in heart rate, cardiac index, systemic blood pressure or systemic and pulmonary vascular resistances. On the whole the cardiac index remained unchanged. There were numerous individual variations of cardiac index in relation to the initial mean pulmonary capillary wedge pressure and the magnitude of its fall following administration of ISDN. The change in cardiac index was inversely correlated with the control cardiac index (r=−0.69, p<0.02).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bardet J, Rocha P, Rigaud M, Bourdarias JP, Mathivat A (1977) Left ventricular compliance in acute myocardial infarction in man. Cardiovasc Res 11: 122–131

    Google Scholar 

  2. Baxter RH, Tait CM, McGuinness JB (1977) Vasodilator therapy in acute myocardial infarction. Use of sublingual isosorbide dinitrate. Br Heart J 39: 1067–1070

    Google Scholar 

  3. Berdeaux A, Giudicelli JF (1982) Effets du dinitrate d'isosorbide sur l'hémodynamique générale, la distribution régionale du sang coronaire et le segment ST. Nouv Presse Méd 11: 2043–2047

    Google Scholar 

  4. Broder MI, Cohn JN (1972) Evolution of abnormalities in left ventricular function after acute myocardial infarction. Circulation 46: 731–743

    Google Scholar 

  5. Bussman WD, Lohner J, Kaltenbach M (1977) Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction. Am J Cardiol 39: 91–96

    Google Scholar 

  6. Chasseaud LF, Taylor T, Doyle E, Darragh A, Lambe R (1983) The bioavaibility of isosorbide dinitrate from Langoran 20 and Langoran 40 capsules after oral administration to human subjects. Int J Clin Pharmacol Ther Toxicol 21: 514–518

    Google Scholar 

  7. Chatterjee K, Parmley WW, Ganz W, Forrester J, Walinsky P, Crexells C, Swan HJC (1973) Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 38: 1183–1193

    Google Scholar 

  8. Cohn JN, Franciosa JA (1977) Vasodilator therapy of cardiac failure (Part II). N Engl J Med 297: 254–258

    Google Scholar 

  9. Crexells C, Chatterjee K, Forrester JS, Dikshit K, Swan HJC (1973) Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med 289: 1263–1266

    Google Scholar 

  10. Delgado CE, Pitt B, Taylor DR, Weisfeldt ML, Kelly Dt (1975) Role of sublingual nitroglycerin in patients with acute myocardial infarction. Br Heart J 37: 392–396

    Google Scholar 

  11. Elkayam U, Aronow WS (1982) Glyceryl trinitrate (Nitroglycerin) ointment and isosorbide dinitrate. A review of their pharmacological properties and therapeutic use. Drugs 23: 165–194

    Google Scholar 

  12. Fukuyama T, Shechtman KB, Roberts R (1980) The effects of intravenous nitroglycerin on hemodynamics, coronary blood flow and morphologically and enzymatically estimated infarct size in conscious dogs. Circulation 62: 1227–1238

    Google Scholar 

  13. Fung HL, McNiff EF, Ruggirello D, Darke A, Thadani U, Parker JO (1981) Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol 11: 579–590

    Google Scholar 

  14. Franciosa JA, Blank RC, Cohn JC (1978) Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. Am J Med 64: 207–213

    Google Scholar 

  15. Franciosa JA, Dunkman NB, Wilen M, Silverstein SR (1983) “Optimal” left ventricular filling pressure during nitroprusside infusion for congestive heart failure. Am J Med 74: 457–464

    Google Scholar 

  16. Gold HK, Leinbach C, Sanders CA (1972) Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation 36: 839–845

    Google Scholar 

  17. Mason D, Braunwald E (1965) The effect of nitroglycerin and amyl nitrate on arteriolar and venous tone in the human fore arm. Circulation 32: 755–766

    Google Scholar 

  18. Packer M, Meller J, Medina N, Gorlin R, Herman R (1979) Dose dependence of the hemodynamic responses to nitrate therapy in patients with refractory congestive heart failure. Clin Res 27: 192A

  19. Packer M, Meller J, Medina N, Gorlin R, Herman R (1979) Equivalent hemodynamic effects of intravenous nitroprusside and high doses of oral isosorbide dinitrate in severe heart failure. Circulation 59–60 [Suppl 2]: II-182 (abstract)

  20. Rosseel MT, Bogaert MG (1973) Determination of nitroglycerin and isosorbide dinitrate in human plasma. J Pharm Sci 62: 754–758

    Google Scholar 

  21. Shah PK, Abdulla A, Pichler M, Shellock F, Berman D, Singh BN, Swan HJC (1983) Effects of nitroprussiate induced reduction of elevated preload and afterload on global and regional ventricular function in acute myocardial infarction. Am Heart J 105: 531–542

    Google Scholar 

  22. Sneatman T, Strauss G, Selzer A, Cohn KE (1972) The long acting hemodynamic effects of isosorbide dinitrate. Am J Cardiol 29: 475–480

    Google Scholar 

  23. Strumza P, Rigaud M, Mechmeche R, Rocha P, Baudet M, Bardet J, Bourdarias JP (1979) Prolonged hemodynamic effects (12 hours) of orally administered sustained — release nitroglycerin. Am J Cardiol 43: 272–276

    Google Scholar 

  24. Szwarc G, Lellouche D, Usdin JP (1982) Utilisation de l'isosorbide dinitrate injectable dans l'insuffisance ventriculaire gauche de la phase aiguë de l'infarctus du myocarde. Nouv Presse Méd 11: 2079–2082

    Google Scholar 

  25. Williams DO, Amsterdam EA, Mason DT (1975) Hemodynamic effects of nitroglycerin in acute myocardial infarction. Circulation 51: 421–427

    Google Scholar 

  26. Williams DO, Bommer WJ, Miller RR, Amsterdam EA, Mason DT (1977) Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effects of isosorbide dinitrate. Am J Cardiol 39: 84–90

    Google Scholar 

  27. Zerzawy R, Bachmann K (1980) Langzeitwirkung von 40 mg Isosorbiddinitrat Plasmaspiegel und Hämodynamik in Ruhe und während Ergometrie im Liegen und Sitzen. In: Rudolph W, Schrey A (eds) Wirkung auf Herz und Kreislauf. Nitrate II. — 2. Nitrat Symposion Berlin, Urban & Schwarzenberg, München, Vienne Baltimore, pp 394–402

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dubourg, O., Gueret, P., Ferrier, A. et al. Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure. Eur J Clin Pharmacol 27, 259–263 (1984). https://doi.org/10.1007/BF00542156

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542156

Key words

Navigation